보건의료정보 표준화 연구 Research of Health Information Standardization
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
November 5, 2003 – Letter to the Secretary – Comments on CHI
November 5, 2003 The Honorable Tommy G. Thompson Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, D.C. 20201 Dear Secretary Thompson: The National Committee on Vital and Health Statistics (NCVHS) commends you for your commitment toward government wide adoption of clinical data standards that you first announced on March 21, 2003. NCVHS recognizes and appreciates that there is new momentum to adopt clinical data standards that is driven by you and the Consolidated Healthcare Informatics Initiative (CHI). Consequently, NCVHS is now working closely with CHI to study, select and recommend domain specific patient medical record information (PMRI) terminology standards. We have mutually developed a process that allows NCVHS to discuss in open, interactive sessions CHI recommendations as part of the CHI Council acceptance process. The NCVHS has the following comments on the attached set of CHI domain area recommendations: • The NCVHS concurs with the CHI recommendations for Interventions and Procedures: Part B, Laboratory Test Order Names. • The NCVHS concurs with the CHI recommendations for the Medication Domain as modified in the attached document. We further note: o the need for additional funding for the Food and Drug Administration (FDA) to expedite the publication of a publicly available version of their Unique Ingredient Identifier (UNII) codes and to provide continued funding to maintain the UNII code standard; o that the dosage and administration sub-domain be investigated in the next phase of the CHI process; and o that the FDA National Drug Code (NDC) process be investigated and improvements identified be expeditiously pursued. • The NCVHS concurs with the CHI recommendations for the Immunization Domain as modified in the attached document. -
Ata Lements for Mergency Epartment Ystems
D ata E lements for E mergency D epartment S ystems Release 1.0 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES CDCCENTERS FOR DISEASE CONTROL AND PREVENTION D ata E lements for E mergency D epartment S ystems Release 1.0 National Center for Injury Prevention and Control Atlanta, Georgia 1997 Data Elements for Emergency Department Systems, Release 1.0 (DEEDS) is the result of contributions by participants in the National Workshop on Emergency Department Data, held January 23-25, 1996, in Atlanta, Georgia, subsequent review and comment by individuals who read Release 1.0 in draft form, and finalization by a multidisciplinary writing committee. DEEDS is a set of recommendations published by the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention: Centers for Disease Control and Prevention David Satcher, MD, PhD, Director National Center for Injury Prevention and Control Mark L. Rosenberg, MD, MPP, Director Division of Acute Care, Rehabilitation Research, and Disability Prevention Richard J. Waxweiler, PhD, Director Acute Care Team Daniel A. Pollock, MD, Leader Production services were provided by the staff of the Office of Communication Resources, National Center for Injury Prevention and Control, and the Management Analysis and Services Office: Editing Valerie R. Johnson Cover Design and Layout Barbara B. Lord Use of trade names is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services. This document and subsequent revisions can be found at the National Center for Injury Prevention and Control Web site: http://www.cdc.gov/ncipc/pub-res/deedspage.htm Suggested Citation: National Center for Injury Prevention and Control. -
(USCDI), Version 1, July 2020 Errata
Allergies and Intolerances .... 5 The USCDI is a standardized Assessment and Plan of set of health data classes and Treatment ............................ 5 Care Team Member(s) ......... 6 constituent data elements for Clinical Notes ........................ 7 nationwide, interoperable Goals ..................................... 8 Health Concerns ................... 8 health information exchange. Immunizations ...................... 9 Laboratory ............................ 9 A USCDI “Data Class” is an aggregation of various Data Elements by a common theme or use case. Medications ........................ 10 Patient Demographics ........ 10 A USCDI “Data Element” is the most granular level Problems ............................ 12 at which a piece of data is represented in the USCDI Procedures ......................... 12 for exchange. Provenance ........................ 13 Smoking Status ................... 13 Unique Device Identifier(s) for a Patient’s Implantable Device(s) ............................. 13 Vital Signs ........................... 14 2 Version History Version # Description of change Version Date 1 First Publication February 2020 1 (July 2020 Corrections to Applicable Standards July 2020 Errata) • Substance (Medication) - Removed UCUM • Patient’s Goals, Health Concerns, Assessment and Plan of Treatment - Removed LOINC, SNOMED CT • Laboratory Tests, Values/Results - Removed SNOMED CT and UCUM • Medications - Removed UCUM 3 USCDI v1 Summary of Data Classes and Data Elements Allergies and Intolerances Laboratory Smoking Status -
Report-Health Terminologies and Vocabularies Environmental Scan
Health Terminologies and Vocabularies Environmental Scan Conducted for the National Committee on Vital and Health Statistics Subcommittee on Standards September 14, 2018 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Terminologies and Vocabularies Environmental Scan NCVHS Subcommittee on Standards This report was written by Susan L. Roy, MS, MLS, SNOMED CT Coordinator, and Vivian A. Auld, MLIS, Senior Specialist for Health Data Standards, both with the National Institutes of Health (NIH), National Library of Medicine, in collaboration with the NCVHS Standards Subcommittee: NCVHS Membership William W. Stead, MD, NCVHS Chair Nicholas L. Coussoule,* Subcommittee Co-chair Alexandra Goss,* Subcommittee Co-chair Bruce B. Cohen, PhD David A. Ross, ScD Debra Strickland, MS* Denise E. Love, BSN, MBA* Jacki Monson, JD Linda L. Kloss, MA, RHIA*, Terminology and Vocabulary Project Lead Llewellyn J. Cornelius, PhD Richard W. Landen, MPH, MBA* Robert L. Phillips, Jr., MD, MSPH Roland J. Thorpe, Jr., PhD Vickie M. Mays, PhD, MSPH *Member of the Subcommittee on Standards Rebecca Hines, MHS, NCVHS Executive Secretary/DFO Health Scientist National Center for Health Statistics, CDC, HHS Rashida Dorsey, PhD, MPH, NCVHS Executive Staff Director Director, Division of Data Policy Senior Advisor on Minority Health and Health Disparities Office of Science and Data Policy Office of the Assistant Secretary for Planning and Evaluation, HHS The National Committee on Vital and Health Statistics (NCVHS) serves as the advisory committee to the Secretary of Health and Human Services (HHS) on health data, statistics, privacy, national health information policy, and the Health Insurance Portability and Accountability Act (HIPAA) (42U.S.C.242k[k]). -
(Child Core Set) Technical Specifications and Reso
Core Set of Children's Health Care Quality Measures for Medicaid and CHIP (Child Core Set) Technical Specifications and Resource Manual for Federal Fiscal Year 2019 Reporting February 2019 Center for Medicaid and CHIP Services Centers for Medicare & Medicaid Services This page left blank for double-sided copying ii ACKNOWLEDGMENTS For Proprietary Codes: CPT® codes copyright 2018 American Medical Association. All rights reserved. CPT is a trademark of the American Medical Association. No fee schedules, basic units, relative values or related listings are included in CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2018 The International Health Terminology Standards Development Organisation. All Rights Reserved. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is published by the World Health Organization (WHO). ICD-9-CM is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 9th Revision, Procedure Coding System (ICD-9-PCS) is published by the World Health Organization (WHO). ICD-9-PCS is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) is published by the World Health Organization (WHO). ICD-10-PCS is an official Health Insurance Portability and Accountability Act standard. This material contains content from LOINC® (http://loinc.org). -
Billing and Coding Considerations for BLINCYTO®
BLINCYTO® Billing Information Sheet Billing and Coding Considerations for BLINCYTO® This Information Sheet is intended to help healthcare professionals understand the key billing and coding considerations for BLINCYTO® and its related services and supplies when using the FDA-approved dosing options in inpatient and outpatient treatment settings. Updates for 2018 include: • Information on billing the 7-day infusion option (7-DIO) in addition to the shorter-duration 24-hour and 48-hour bags BLINCYTO® Dosing Options1 Dose per vial X number of Dosing option Number of billing units single-dose vials (SDVs*) 24-hour 35 mcg X 1 vial 35 48-hour 35 mcg X 1-2 vials 35-70 7-day 35 mcg X 4-6 vials 140-210 • New coding requirement for BLINCYTO® administered in the outpatient setting of 340B hospitals – The Centers for Medicare & Medicaid Services (CMS) requires use of new modifiers on Medicare claims for drugs acquired under the 340B Drug Discount Program2 • Medicare patients receiving BLINCYTO® in the inpatient setting are no longer eligible for additional reimbursement3 – The new technology add-on payment (NTAP) designation has been retired; hospitals may still be eligible for outlier payments based on payer guidance and managed care contract provisions *Number of SDVs depends on dose, infusion duration, and patient's weight.1 Please note that the information in this resource is intended to be educational and is not a guarantee of reimbursement. Coverage, coding, and billing requirements vary by health plan so be sure to check with individual payers for detailed guidance. Indications BLINCYTO® is indicated for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1% in adults and children. -
The Role of Family Practice in Different Health Care Systems
January 2002 · Vol. 51, No. 1 JFP ONLINE The Role of Family Practice in Different Health Care Systems A Comparison of Reasons for Encounter, Diagnoses, and Interventions in Primary Care Populations in the Netherlands, Japan, Poland, and the United States I.M. Okkes, MA, PhD; G.O. Polderman, MD; G.E. Fryer, PhD; T. Yamada, MD; M. Bujak, MD; S.K. Oskam, MSc, PhD; L.A. Green, MD; H. Lamberts, MD, PhD Amsterdam and Amstelveen, the Netherlands; Tokyo, Japan; Katowice, Poland; and Washington, DC Submitted, revised, October 21, 2001. From the Academic Medical Center/University of Amsterdam, Division of Public Health, Department of Family Practice, Amsterdam (I.M.O., S.K.O., H.L.); Family Physician, Transition Project, Amstelveen (G.O.P.); the Robert Graham Center: Policy Studies in Family Practice and Primary Care, Washington, DC (G.E.F., L.A.G.); the Japanese Association for Development of Community Medicine, Tokyo (T.Y.); and the Silesian Medical School, Katowice (M.B.). Reprint requests should be addressed to I.M. Okkes, MA, PhD, Academic Medical Center/University of Amsterdam, Division Public Health, Department of Family Practice, Meibergdreef 15, 1105 AZ Amsterdam, the Netherlands. E-mail: [email protected]. z OBJECTIVE: Our goal was to compare the content of family practice in different countries using databases containing information on reasons for encounter, diagnoses, and interventions that are coded with or can be addressed by the International Classification of Primary Care (ICPC). z STUDY DESIGN: In the Netherlands, Japan, and Poland data were collected identically with an electronic patient record (Transhis). -
2018 Annual Surveillance Report of Drug-Related Risks and Outcomes
2018 ANNUAL SURVEILLANCE REPORT OF DRUG-RELATED RISKS AND OUTCOMES UNITED STATES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Annual Surveillance Report of Drug-Related Risks and Outcomes | United States CDC National Center for Injury Prevention and Control | 2018 ACKNOWLEDGEMENTS This Surveillance Report was prepared by staff from the National Disclaimer Center for Injury Prevention and Control (NCIPC), Centers for Disease The findings and conclusions in Control and Prevention (CDC), U.S. Department of Health and Human this report are those of the authors Services, Atlanta, Georgia. and do not necessarily represent the views of the Centers for Disease Control and Prevention. This Contributors to this report included: Brooke E. Hoots, PhD, MSPH1, 2 3 research was supported in part by Likang Xu, MD, MS , Mbabazi Kariisa, PhD , Nana Otoo Wilson, PhD, an appointment to the Research 1 1 1,4 MPH, MSc , Rose A. Rudd, MSPH , Lawrence Scholl, PhD, MPH , Lyna Participation Program at the Centers 1 1 Schieber, MD, DPhil , and Puja Seth, PhD for Disease Control and Prevention 1Division of Unintentional Injury Prevention (DUIP), National Center for administered by the Oak Ridge Injury Prevention and Control, CDC Institute for Science and Education 2Division of Analysis, Research, and Practice Integration (DARPI), through an interagency agreement National Center for Injury Prevention and Control, CDC between the U.S. Department of 3Oak Ridge Institute for Science and Education, Oak Ridge, TN Energy and CDC. 4Epidemic Intelligence Service, CDC All material in this report is in the public domain and may be used Corresponding authors: Brooke E. -
Coding Basics
Coding Basics 60889-R5-V1 • This information is provided for your background education and is not intended to serve as guidance for specific coding, billing, and claims submissions. The decision on which codes best describe the services provided must be made by the individual providers based on specific payor guidance and requirements. 2 Agenda • Define each code set – HCPCS – CPT® – NDC – ICD-9-CM – ICD-10-CM • Discuss general formats • Apply coding basics to sample claim forms – Physician office setting (CMS-1500 claim form) – Hospital outpatient setting (UB-04 claim form) CPT is a registered trademark of the American Medical Association. All rights reserved. 3 Healthcare Common Procedure Coding System (HCPCS)1 HCPCS codes describe products, supplies, items and services not included in CPT They establish a standard coding system that allow claims to be processed in a consistent manner The use of the HCPCS is mandatory • It is alpha-numeric. The format is a single alphabetical letter (A to V) followed by 4 numeric digits • Maintained by Centers for Medicare and Medicaid Services (CMS) 1. Centers for Medicare & Medicaid Services (CMS), New CMS Coding Changes Will Help Beneficiaries. https://www.cms.gov/MedHCPCSGenInfo/Downloads/HCPCSReform.pdf. Accessed January 30, 2012. 4 Current Procedural Terminology (CPT)1 Developed by the American Medical Association (AMA), it is a list of descriptive terms that identify medical services and procedures It allows for communication of uniform information among physicians, coders, patients, and payers Category I CPT codes •Describe a procedure or service identified with a 5-digit code and descriptor nomenclature Category II CPT Codes •Supplemental tracking codes that can be used for performance measurement (optional) Category III CPT Codes •Temporary set of tracking codes for new and emerging technologies intended to facilitate data collection on and assessment of new services and procedures 1. -
Who Gets Medication-Assisted Treatment for Opioid Use Disorder, and Does It Reduce Overdose Risk? Evidence from the Rhode Island All-Payer Claims Database Mary A
No. 21-3 Who Gets Medication-assisted Treatment for Opioid Use Disorder, and Does It Reduce Overdose Risk? Evidence from the Rhode Island All-payer Claims Database Mary A. Burke, Riley Sullivan, Katherine Carman, Hefei Wen, J. Frank Wharam, and Hao Yu Abstract: This paper uses the all-payer claims database (APCD) for Rhode Island to study three questions about the use of medication-assisted treatment (MAT) for opioid use disorder (OUD): (1) Does MAT reduce the risk of opioid overdose; (2) are there systematic differences in the uptake of MAT by observable patient-level characteristics; and (3) how successful were federal policy changes implemented in 2016 that sought to promote increased use of buprenorphine, one of three medication options within MAT? Regarding the first question, we find that MAT as practiced in Rhode Island is associated with a reduced risk of repeated opioid overdose among patients who had an initial nonfatal opioid overdose, consistent with the strong endorsement of MAT by public health officials. Concerning the second, we find that factors such as age, gender, health insurance payer, and the poverty rate in one’s residential Zip code are associated with significant differences in the chance of receiving methadone and/or buprenorphine, suggesting that certain groups may face unwarranted disparities in access to MAT. About the third question, we find that a 2016 federal rule change enabled at least some experienced Rhode Island buprenorphine prescribers to reach more patients, and a separate 2016 policy aimed at recruiting new buprenorphine prescribers was also found to be effective. However, the data also suggest that many more patients in the state could be treated with buprenorphine if prescribers took full advantage of their prescribing limits. -
Common Semantic Strategy for Health in the European Union WP8 Integration in National Policies and Sustainability Draft
D8.2.2 Common Semantic Strategy for Health in the European Union WP8 Integration in National Policies and Sustainability Draft Revision 1.4, 10-05-2019 15th eHN meeting, June 2019 For Discussion Grant Agreement nº 801558 D8.2.2 Common Semantic Strategy WP8 Integration in National Policies and Sustainability Draft for Discussion Revision 1.4, 10-05-2019 CONTROL PAGE OF DOCUMENT Document name CSS for Health in the EU – Information paper for eHN Status Draft Author(s) Country Organisation Name Austria Sozial Ministerium Peter Brosch Croatia HZZO Vesna Kronstein Kufrin Czech Republic MoH Czech Republic Hynek Kruzik Estonia HWISC Kerli Linna Finland THL Mikko Härkönen Germany DIMDI Stefanie Weber Hungary AEEK Gergely Heja Eamon Coyne; Ireland HSE Theresa Barry Lithuania LMB Martynas Bieliauskas Netherlands NICTIZ Pim Volkert Norway EHELSE Jostein Vein MoH Poland Hubert Zycinski; Poland CZIOZ Ania Ostrowicka Henrique Martins; Diogo Martins; Jurgen Wehnert; Lilia Marques; Cristiana Antunes; Filipa Rasquinho; Portugal SPMS Daniela Costa; Filipe Mealha; Joana Cunha; Carla Pereira; Anabela Santos; Anderson do Carmo Slovenia NIJZ Lucija Tepej-Jocic Arturo Romero Gutiérrez; Spain MoH Spain Miguel Pedrera Jiménez Sweden Socialstyrelsen Daniel Karlsson 2/31 eHAction – Joint Action supporting the eHealth Network - www.ehaction.eu D8.2.2 Common Semantic Strategy WP8 Integration in National Policies and Sustainability Draft for Discussion Revision 1.4, 10-05-2019 REVISION HISTORY Revision Date Author Description Daniel Karlsson; Stefanie Weber; Mikko Härkönen; Vesna Kronstein Kufrin; Hynek st 0.1 11/02/2019 Kruzik; Hubert Zycinski; Kerli Linna 1 draft document Input of new content. 0.2 25/02/2019 Carla Pereira; Daniela Costa; Lucija Tepej-jocic Comments on the Document 0.3 05/03/2019 Arturo Romero; Jurgen Wehnert Comments on the Document Peter Brosch; Hynek Kruzik;Daniel Karlsson; Input of new content. -
D8.2 - Policy Document About Technology Report
D8.2 - Policy document about technology report WP8 - Integration in National Policies and Sustainability 08/06/2021 Version 1.0 Grant Agreement nº 801558 This document presents the work regarding the policy technology on eHealth. Through the huge level of information and granularity associated with this subject, this deliverable contains four chapters about: Electronic health record exchange format (EHRxF); the Common Semantic strategy (CSS); eHealth reference architecture (eHRA) and Common Strategy for the use of Digital Identification in Health in the European Union (eID). D8.2 – Policy document about technology report WP8 - Integration in National Policies and Sustainability Version 1.0, 08/06/2021 CONTROL PAGE OF DOCUMENT Document name D8.2 – Policy document about technology report Work Package WP1 - Coordination Dissemination level PU Status Approved Author(s) Country Organisation Name Sozial Ministerium Peter Brosch (CSS) Austria ELGA Stefan Sabutsch (EHRxF, CSS) GOEG Alexander Degelsegger-Márquez (eHRA) Federal Public Service Arabella D'Havé (CSS) of Health, Food Chain Belgium Safety and Environment Croatia HZZO Jelena Curać (EHRxF), Vesna Kronstein Kufrin (CSS); Ammochostos General Florentia Zeitouni (EHRxF) Cyprus Hospital MoH CY Vasilios Scoutellas (CSS) Czech Republic MoH Czech Republic Hynek Kruzik (All) Denmark Sundhedsdatastyrelsen Camilla Wiberg Danielsen (CSS) Estonia HWISC Katre Pruul (EHRxF), Kerli Linna (CSS) THL Heikki Virkkunen (EHRxF) Juha Mykkänen (EHRxF) Finnish Institute for Finland Health and Welfare Mikko Härkönen